Specialized Alcohol Research Centers (P50 Clinical trial Optional)
ID: 354051Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $1M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354051

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-24-007.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity for the establishment of Specialized Alcohol Research Centers (P50), aimed at fostering interdisciplinary research on Alcohol Use Disorder (AUD) and related health issues. This initiative encourages collaborative efforts to enhance understanding, treatment, and prevention of AUD across diverse populations, with a focus on developing innovative research methods and technologies. Eligible applicants include various educational institutions, nonprofits, and government entities, with a total funding amount of up to $7 million available for fiscal year 2026. Applications are due by November 15, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-AA-24-007-Full-Announcement.html
    RFA-AA-24-007.html
    The National Institute on Alcohol Abuse and Alcoholism (NIAAA) has announced a funding opportunity for the establishment of Specialized Alcohol Research Centers (P50). The initiative seeks to promote interdisciplinary and collaborative research on Alcohol Use Disorder (AUD) and related health issues, guiding advancements in understanding, treatment, and prevention across diverse populations. This reissued funding opportunity, RFA-AA-24-007, entails a budget of up to $7 million for fiscal year 2026, with applications due by November 15, 2024. Key components of successful applications include a Plan for Enhancing Diverse Perspectives (PEDP), which is mandatory and shall be evaluated alongside scientific merit. This PEDP aims to foster inclusivity and leverage diverse viewpoints in research proposals. Eligible applicants can include various higher education institutions, nonprofits, and government entities, provided they have completed requisite registrations. The funding supports comprehensive research themes and stimulates the development of pilot projects. Applications will be evaluated based on criteria such as significance, investigator expertise, innovation, and approach, ensuring robust scientific inquiry geared towards impactful research on AUD.
    Similar Opportunities
    Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for Comprehensive Alcohol Research Centers (P60), aimed at fostering interdisciplinary research on Alcohol Use Disorder (AUD) and related issues. Applicants are required to establish a Dissemination Core to enhance community education and public health outreach, particularly focusing on underserved populations, while also incorporating a Plan for Enhancing Diverse Perspectives (PEDP) in their proposals. This initiative is crucial for advancing understanding and interventions related to alcohol misuse, with a total funding availability of up to $7 million for FY 2026. Interested organizations must submit their applications through Grants.gov by November 15, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Alcohol Health Services Research (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a funding opportunity titled "Alcohol Health Services Research (R34 Clinical Trial Optional)" (PAR-23-252). This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on improving access to treatment, reducing stigma, examining cost structures, and implementing evidence-based approaches, particularly for health disparity populations. The total project budget is capped at $450,000 over a three-year period, and eligible applicants include higher education institutions, nonprofits, and government agencies, with a specific emphasis on those serving underrepresented communities. Interested parties should submit their applications electronically by October 16, 2023, with funding available until September 8, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Alcohol Health Services Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for the Alcohol Health Services Research (R01 Clinical Trial Optional) grant. This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on five key areas: increasing access to treatment, enhancing the appeal of treatment, examining cost structures and insurance systems, studying the dissemination and implementation of evidence-based approaches, and reducing health disparities among affected populations. The grant allows for a maximum budget of $500,000 and a project period of up to five years, with applications due by September 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)" aimed at advancing research in the treatment and recovery from alcohol use disorder (AUD). This grant supports clinical trials focusing on various aspects of AUD, including medication development, behavioral therapies, and innovative treatment technologies, particularly for populations facing health disparities. The funding is crucial for enhancing the understanding and efficacy of AUD treatments, ultimately contributing to improved public health outcomes. Eligible applicants can receive up to $500,000 in direct costs over a maximum project period of five years, with key submission deadlines on October 5, 2023, and February 5, 2024. For more information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-250.html.
    Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) aimed at supporting the development of medications for Alcohol Use Disorder (AUD) and Alcohol-Associated Organ Damage (AAOD) through Small Business Innovation Research (SBIR) applications. Eligible applicants, specifically U.S.-based small businesses, are required to propose therapeutic agents that have a solid foundation of background data, ready for transition to preclinical and clinical development, with a focus on advancing these candidates towards FDA approval. This initiative is critical given the limited FDA-approved treatments available for AUD and AAOD, and it emphasizes the importance of rigorous scientific and regulatory standards in drug development. Funding amounts include up to $1 million for Phase I and $1.5 million for Phase II, with project durations of up to two years and three years, respectively. Interested parties can find more information and contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with the application deadline set for December 4, 2024.
    Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the R34 Clinical Trial mechanism focused on Alcohol Treatment, Pharmacotherapy, and Recovery Research. This initiative aims to enhance understanding and treatment strategies for Alcohol Use Disorder (AUD) through clinical trials, with a particular emphasis on increasing access to treatment, improving treatment appeal, examining cost structures, and addressing health disparities among affected populations. The program is open to a diverse range of applicants, including educational institutions, nonprofits, and government agencies, with funding limits set at $450,000 over a maximum three-year project period. Interested parties must submit their applications by October 16, 2023, and can direct inquiries to grantsinfo@nih.gov for further information.
    Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed), aimed at supporting investigator-initiated resources that enhance biomedical, behavioral, and social sciences research related to alcohol. This grant mechanism focuses on providing essential data, materials, and services to the broader alcohol research community, rather than supporting hypothesis-driven research, which should be submitted through other mechanisms. The NIH seeks to create high-quality resources that do not duplicate existing offerings, emphasizing the importance of diversity in research participation and encouraging applications from organizations serving underrepresented groups. Applications are due by January 25, 2024, and the project periods can last up to five years, with no cost-sharing or matching requirements. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics (U54 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity to establish a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through a cooperative agreement. This initiative aims to provide technical development support for researchers working on new digital therapeutics for SUD, facilitating the transition from initial ideas to market-ready products. The program addresses the critical gap in early translational funding and aims to enhance the landscape of treatment options for substance use disorders by mentoring and educating researchers in formal product development. The maximum funding amount is $1.9 million per year, with applications accepted until November 13, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-056.html.
    Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)" aimed at supporting research on strategies to prevent and intervene in fetal alcohol spectrum disorders (FASD). The initiative seeks proposals that focus on reducing prenatal alcohol exposure and improving interventions for individuals affected by FASD, utilizing the Exploratory/Developmental Phased Award (R61/R33) mechanism, which allows for pilot studies in the initial phase and potential expansion in the subsequent phase based on milestone achievements. This funding is crucial for addressing significant public health challenges related to prenatal alcohol exposure, with a total award ceiling of $350,000 and no cost-sharing requirements. Interested applicants must submit their proposals by January 16, 2024, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-068.html.
    Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (UT1/UT2 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for Small Business Technology Transfer (STTR) applications aimed at the development of new therapeutic agents for Alcohol Use Disorder (AUD) and Alcohol-Associated Organ Damage (AAOD). Eligible applicants must propose projects that demonstrate substantial preclinical data and aim to advance therapeutic candidates through various stages of drug development, potentially leading to FDA approval. This initiative is particularly significant in addressing public health needs related to alcohol-related disorders, with a focus on safety, efficacy, and regulatory submissions. Interested small businesses, especially those that are women-owned or disadvantaged, must submit their applications by December 4, 2024, and can find additional information and guidelines at the NIH grants website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.